Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells
about
The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensationActivation and function of the MAPKs and their substrates, the MAPK-activated protein kinasesInsights into the inhibition of the p90 ribosomal S6 kinase (RSK) by the flavonol glycoside SL0101 from the 1.5 Å crystal structure of the N-terminal domain of RSK2 with bound inhibitor.Identification of quercitrin as an inhibitor of the p90 S6 ribosomal kinase (RSK): structure of its complex with the N-terminal domain of RSK2 at 1.8 Å resolutionMolecular composition of staufen2-containing ribonucleoproteins in embryonic rat brainExtracellular Signal-regulated Kinase (ERK)-dependent Phosphorylation of Y-Box-binding Protein 1 (YB-1) Enhances Gene Expression in Granulosa Cells in Response to Follicle-stimulating Hormone (FSH)RSK in tumorigenesis: connections to steroid signaling.Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer.YB-1 evokes susceptibility to cancer through cytokinesis failure, mitotic dysfunction and HER2 amplificationYB-1 regulates Sox2 to coordinately sustain stemness and tumorigenic properties in a phenotypically distinct subset of breast cancer cellsY-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance.Identification of Y-box binding protein 1 as a core regulator of MEK/ERK pathway-dependent gene signatures in colorectal cancer cellsSelf-reinforcing loop of amphiregulin and Y-box binding protein-1 contributes to poor outcomes in ovarian cancer.Calcineurin-mediated YB-1 dephosphorylation regulates CCL5 expression during monocyte differentiation.Molecular decoy to the Y-box binding protein-1 suppresses the growth of breast and prostate cancer cells whilst sparing normal cell viability.Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1TLR and TNF-R1 activation of the MKK3/MKK6-p38α axis in macrophages is mediated by TPL-2 kinase.Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1)Overcoming resistance to Sonic Hedgehog inhibition by targeting p90 ribosomal S6 kinase in pediatric medulloblastoma.YB-1 transforms human mammary epithelial cells through chromatin remodeling leading to the development of basal-like breast cancerImpact of oncogenic K-RAS on YB-1 phosphorylation induced by ionizing radiation.Status of epigenetic chromatin modification enzymes and esophageal squamous cell carcinoma risk in northeast Indian population.Y-Box Binding Protein 1 Stabilizes Hepatitis C Virus NS5A via Phosphorylation-Mediated Interaction with NS5A To Regulate Viral Propagation.Interplay between YB-1 and IL-6 promotes the metastatic phenotype in breast cancer cells.Peritoneal and hematogenous metastases of ovarian cancer cells are both controlled by the p90RSK through a self-reinforcing cell autonomous mechanism.Inherited and acquired alterations in development of breast cancer.Targeted therapy for breast cancer prevention.Radiation-induced gene signature predicts pathologic complete response to neoadjuvant chemotherapy in breast cancer patientsInsulin activates RSK (p90 ribosomal S6 kinase) to trigger a new negative feedback loop that regulates insulin signaling for glucose metabolism.YB-1 dependent oncolytic adenovirus efficiently inhibits tumor growth of glioma cancer stem like cells.Targeting tumour-initiating cells to improve the cure rates for triple-negative breast cancer.YB-1: oncoprotein, prognostic marker and therapeutic target?YB-1 protein: functions and regulation.Association of breast cancer risk and the mTOR pathway in women of African ancestry in 'The Root' Consortium.Human melanoma cells resistant to MAPK inhibitors can be effectively targeted by inhibition of the p90 ribosomal S6 kinaseY-box-binding protein 1 contributes to IL-7-mediated survival signaling in B-cell precursor acute lymphoblastic leukemia.Inhibition of RSK/YB-1 signaling enhances the anti-cancer effect of enzalutamide in prostate cancer.Targeting ribosomal S6 kinases/Y-box binding protein-1 signaling improves cellular sensitivity to taxane in prostate cancer.Antitumor effects of BI-D1870 on human oral squamous cell carcinoma.RSK-mediated nuclear accumulation of the cold-shock Y-box protein-1 controls proliferation of T cells and T-ALL blasts.
P2860
Q24616946-26C519DA-A5BB-48DB-A1EB-3663BAE4DA74Q24632768-815DDAF7-1975-4BCC-B0E3-B3910E7D9951Q27670966-4819B43C-B572-4F95-A2C0-750AE667088EQ27676158-9C93FC1E-D68B-4C8C-A58B-2A7A968F8F0EQ28578347-183335A8-A4A7-4527-A91C-1313887EF451Q30352429-D40AC94D-EA6C-4944-9AA0-2F196869C86CQ30433106-9A7B6336-B65E-4C8C-98F2-9CD0D18BF7A1Q30908486-B2215ED6-5715-446B-A2BA-7D021CE4C66DQ33292142-3577A1CE-16D7-45D3-A5E1-33BFBC8F297AQ33628528-51B93C97-127F-4B44-9D72-5CF9A1C27043Q33766973-2E812451-5D37-4CF6-AEB5-4237CEC274ABQ33775667-D74222E8-39BD-40FD-9476-D7EFF99EBEC6Q33972424-860F3F40-5EB0-4226-886A-A7177B98A93AQ33985284-9B2BF6F3-4274-4C60-8853-E94231A15669Q34117426-3B75A402-E8FF-49EE-8337-31097E3F9539Q34430583-6B0F2D3C-24E1-4D73-9050-031C9B1E66AAQ34533855-BE97E3EC-0EC0-4C12-A0C6-FAC79692F3AFQ34675192-C43D88D5-98FF-4D0E-B80C-8D16B2575446Q34934082-CCE390CE-5765-4963-BFB6-247B4BE55CD2Q35063920-6489A1B0-E9B8-43D6-A6E2-28E58F3C589BQ35558949-5B1684D3-FF22-4382-916B-018D247972D2Q35666409-CEC453CD-064E-408E-991C-980B4A812616Q36281839-AB157AF4-57C1-4FA5-BDD5-9FC14F77759FQ36546008-6C612D84-5E9D-4B1A-875B-C001941C709FQ36729513-28BF0190-241C-4335-861B-52ACEC47E755Q36925229-182A1465-6D17-4AB4-AA9A-AAD13F4FC373Q37190825-22F5FD31-82CE-43BA-BA53-1F981F03820BQ37244377-349498A3-B592-4995-8A76-A45225678B94Q37312198-3C1A6A93-2D7B-48E9-ADF5-0CA2D5DD1221Q37360181-3C6BD71F-FAEB-4577-BC06-9A97188D56A0Q37775105-041423CA-FEA8-4ECF-80D5-786671D33A76Q38065264-1183E512-E1A4-4945-97B1-E218EE341F98Q38161834-61FF84D5-7799-4CB4-87E5-076533892B9AQ38743221-2EF44AA7-726C-4A4A-B820-1A50CDB33755Q38834031-2B01A4DB-6889-4968-9133-4B9D881DF012Q38998632-6D62FDBC-F95C-496F-AB50-522663D53270Q39003326-3918935B-2D2B-4954-8CC5-56521E957E9CQ39004481-4E3485CE-D2AD-41FB-AFE3-50BB293878C0Q39062314-5C69A25E-B0F6-4087-A9D5-80D540596FEAQ39069088-8776B866-F820-47BA-A99A-8AB38838B3A4
P2860
Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Y-box binding protein-1 serine ...... basal-like breast cancer cells
@en
Y-box binding protein-1 serine ...... asal-like breast cancer cells.
@nl
type
label
Y-box binding protein-1 serine ...... basal-like breast cancer cells
@en
Y-box binding protein-1 serine ...... asal-like breast cancer cells.
@nl
prefLabel
Y-box binding protein-1 serine ...... basal-like breast cancer cells
@en
Y-box binding protein-1 serine ...... asal-like breast cancer cells.
@nl
P2093
P2860
P356
P1476
Y-box binding protein-1 serine ...... basal-like breast cancer cells
@en
P2093
Alastair H Davies
Anna L Stratford
Christopher J Fry
Curtis Desilets
Isabelle M Berquin
Sandra E Dunn
Yong Y Cho
Zigang Dong
P2860
P2888
P356
10.1186/BCR2202
P577
2008-11-27T00:00:00Z
P5875
P6179
1010998788